What Steris's FY2026 10-K says: 12 signals
Steris filed its latest 10-K with the SEC on May 29, 2026. It discusses CFO change, chief compliance officer change and competitor named.
Public (STE)Medical Equipment Manufacturing10,000+ employeessteris.comLinkedIn
- Filed
- May 29, 2026
- Period
- FY2026
- Fiscal year end
- 03/31
- Filings
- 1
10-K · latest 10
What Steris's 10-K filings say
- SEC EDGAR
10-K · FY2026
Filed · Fiscal year ends 03/31 · 12 signals
The promotion of Karen L.
STERIS appointed new CFO, Chief Compliance Officer, and GM of AST in FY2025-2026
The company has undergone significant leadership changes, including appointing Karen L.
New Chief Compliance and Quality Officer Lindsey M. McGowan appointed in January 2026
Lindsey M. McGowan's appointment as Chief Compliance and Quality Officer in January 2026 signals a potential review of quality management systems (QMS), regulatory compliance software, and training platforms to align with her new leadership.
STERIS names over 20 direct competitors across its Healthcare, AST, and Life Sciences segments
The company explicitly identifies a wide range of competitors, including 3M, Baxter, Boston Scientific, Stryker, Olympus, and Ecolab, indicating intense competitive pressure.
3MBaxterBoston ScientificBelimed
STERIS reports single-source dependency for key raw materials Cobalt-60 and Ethylene Oxide.
The company is dependent on a few or single suppliers for critical materials like cobalt-60 and ethylene oxide for its AST operations.
accelerator-based technologies
Facing potential supply chain disruption from USMCA trade agreement review starting July 1, 2026.
The upcoming six-year review of the USMCA trade agreement poses a significant risk to STERIS's manufacturing and supply chain operations in Canada and Mexico.
Faces intense competition in Healthcare segment from 3M, Stryker, Olympus, and others.
STERIS competes with a wide range of large, global companies and smaller niche players in its core Healthcare segment.
3MBaxterBoston ScientificBelimed
STERIS divested its Dental segment in fiscal 2025 to focus on core business units
The company sold its Dental segment to sharpen its focus on the Healthcare, AST, and Life Sciences segments.
STERIS is driving a formal continuous improvement framework based on Lean principles across manufacturing, service, and back-office functions.
Lean principles
Upcoming USMCA trade agreement review on July 1, 2026 poses risk to North American supply chain
The company highlights the formal six-year review of the USMCA trade agreement, starting July 1, 2026, as a specific risk factor.
Showing 10 of 12 filing signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Steris with the Signal API
One POST /v1/companies/enrich call with steris.com returns Steris 10-K signals (sec-10k), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"steris.com","signal_types":["sec-10k"],"limit":20}'Same industry
10-K at related companies
Questions about Steris 10-K
When did Steris file its latest 10-K?
What does Steris's latest 10-K say about CFO change?
Where can I find Steris's annual report?
Source. Annual reports (Form 10-K) filed with the SEC. Every card links to the filing on EDGAR.
Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.
Data as of .